SNORD124: A Potential Drug Target and Biomarker (G101340251)

Target Name: SNORD124

NCBI ID: G101340251

SNORD124

Other Name(s): Small nucleolar RNA, C/D box 124 | small nucleolar RNA, C/D box 124

SNORD124: A Potential Drug Target and Biomarker

S銉庛兗銉?124 (SNORD124) is a novel protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. SNORD124 is a nuclear protein that is expressed in a variety of tissues and cells in the body, including brain, muscle, heart, and immune cells. Its unique structure and expression pattern make it an attractive target for drug developers due to its potential to modulate cellular behavior and promote therapeutic responses.

Drug Target Potential

SNORD124 has been shown to play a critical role in a variety of cellular processes that are important for disease progression. One of its well-established functions is its role in the regulation of mitochondrial function and metabolism. SNORD124 has been shown to interact with the protein p27, which is a key regulator of mitochondrial stress response. By modulating the activity of p27, SNORD124 has been shown to contribute to the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its role in mitochondrial function, SNORD124 has also been shown to play a critical role in the regulation of cellular signaling pathways that are involved in disease progression. For example, SNORD124 has been shown to be involved in the regulation of the T-cell receptor (TCR) signaling pathway, which is involved in the development of cancer.

Biomarker Potential

SNORD124 has also been shown to be a potential biomarker for a variety of diseases. Its unique expression pattern and stability in different tissues make it an attractive candidate for diagnostic applications. For example, studies have shown that SNORD124 is expressed in a variety of tissues and cells, including brain, muscle, heart, and immune cells. This makes it a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a biomarker, SNORD124 has also been shown to be involved in the regulation of cellular processes that are important for disease progression. For example, SNORD124 has been shown to play a critical role in the regulation of the apoptosis (programmed cell death) pathway, which is involved in the elimination of damaged or dysfunctional cells.

Molecular Mechanisms

The molecular mechanisms underlying SNORD124's functions are not well understood, and further research is needed to fully understand its role in disease progression. However, studies have shown that SNORD124 plays a critical role in the regulation of mitochondrial function and metabolism, as well as the regulation of cellular signaling pathways that are involved in disease progression.

Conclusion

SNORD124 is a novel protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and expression pattern make it an attractive target for drug developers due to its potential to modulate cellular behavior and promote therapeutic responses. Further research is needed to fully understand its role in disease progression and its potential as a biomarker.

Protein Name: Small Nucleolar RNA, C/D Box 124

The "SNORD124 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD124 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets